IFP Advisors, Inc - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 210 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$6
-99.9%
30
-9.1%
0.00%
Q3 2022$7,0000.0%330.0%0.00%
Q2 2022$7,000
-12.5%
33
-10.8%
0.00%
Q1 2022$8,000
+700.0%
37
+825.0%
0.00%
Q4 2021$1,0000.0%40.0%0.00%
Q3 2021$1,0000.0%40.0%0.00%
Q2 2021$1,0000.0%4
-20.0%
0.00%
Q1 2021$1,0005
+25.0%
0.00%
Q4 2020$0
-100.0%
4
-88.6%
0.00%
Q3 2020$3,000
-25.0%
350.0%0.00%
Q2 2020$4,000
-60.0%
35
-72.9%
0.00%
-100.0%
Q1 2020$10,000
-37.5%
129
-15.7%
0.00%0.0%
Q4 2019$16,000
-44.8%
153
-50.5%
0.00%
-50.0%
Q3 2019$29,000
+222.2%
309
+382.8%
0.00%
+100.0%
Q4 2018$9,000
-35.7%
64
+25.5%
0.00%0.0%
Q3 2018$14,000
+16.7%
51
-15.0%
0.00%0.0%
Q2 2018$12,000
+9.1%
60
-27.7%
0.00%
Q1 2018$11,0000.0%830.0%0.00%
Q4 2017$11,000
-65.6%
83
-64.2%
0.00%
-100.0%
Q3 2017$32,000
+6.7%
232
-4.5%
0.00%0.0%
Q2 2017$30,000
-18.9%
243
-29.8%
0.00%
-50.0%
Q1 2017$37,000
+362.5%
346
+316.9%
0.00%
Q4 2016$8,000
-27.3%
83
-19.4%
0.00%
-100.0%
Q3 2016$11,000
-31.2%
103
-21.4%
0.00%0.0%
Q2 2016$16,000
+14.3%
131
+4.8%
0.00%0.0%
Q4 2015$14,0001250.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Knott David M Jr 115,000$7,6822.90%
VILLERE ST DENIS J & CO LLC 483,347$32,2872.52%
Monarch Partners Asset Management LLC 62,327$4,163,4441.23%
Chicago Capital, LLC 319,054$21,312,8201.18%
RICE HALL JAMES & ASSOCIATES, LLC 285,634$19,080,3511.09%
Stephens Investment Management Group LLC 454,416$30,713,9770.56%
Smith, Graham & Co., Investment Advisors, LP 65,372$4,366,8500.53%
WOODSTOCK CORP 55,014$3,674,9350.49%
Court Place Advisors, LLC 15,533$1,037,6050.38%
ISTHMUS PARTNERS, LLC 19,830$1,324,6440.20%
View complete list of LIGAND PHARMACEUTICALS INC shareholders